Multimerized IgG1 Fc molecule as an anti-inflammatory agent
- 14 May 2018
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 14 (7) , 390-392
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis opticaNeuropharmacology, 2018
- rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRsThe Journal of Immunology, 2018
- Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous ImmunoglobulinTrends in Immunology, 2017
- IVIG-mediated effector functions in autoimmune and inflammatory diseasesInternational Immunology, 2017
- Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitorsScience Translational Medicine, 2016
- Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applicationsScientific Reports, 2015
- Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravisJournal of Autoimmunity, 2014
- Intravenous Immune Globulin in Autoimmune and Inflammatory DiseasesNew England Journal of Medicine, 2012
- Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in miceArthritis Research & Therapy, 2012
- Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpuraThe Lancet, 1993